1997

  1. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease

  2. Infliximab for induction of remission in CD

  3. Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: Results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group

  4. Smoking and IBD risk (case-control. Israel)

  5. Smoking and IBD risk (case-control. Spain)

  6. Pre-illness dietary factors in IBD (Case-control Israel)

  7. Infliximab for induction of remission in CD